Cargando…

The Review of Insulin Pens—Past, Present, and Look to the Future

Currently, there are about 150–200 million diabetic patients treated with insulin globally. The year 2021 is special because the 100th anniversary of the insulin discovery is being celebrated. It is a good occasion to sum up the insulin pen technology invention and improvement which are nowadays the...

Descripción completa

Detalles Bibliográficos
Autores principales: Masierek, Małgorzata, Nabrdalik, Katarzyna, Janota, Oliwia, Kwiendacz, Hanna, Macherski, Maksymilian, Gumprecht, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959107/
https://www.ncbi.nlm.nih.gov/pubmed/35355552
http://dx.doi.org/10.3389/fendo.2022.827484
_version_ 1784677076984397824
author Masierek, Małgorzata
Nabrdalik, Katarzyna
Janota, Oliwia
Kwiendacz, Hanna
Macherski, Maksymilian
Gumprecht, Janusz
author_facet Masierek, Małgorzata
Nabrdalik, Katarzyna
Janota, Oliwia
Kwiendacz, Hanna
Macherski, Maksymilian
Gumprecht, Janusz
author_sort Masierek, Małgorzata
collection PubMed
description Currently, there are about 150–200 million diabetic patients treated with insulin globally. The year 2021 is special because the 100th anniversary of the insulin discovery is being celebrated. It is a good occasion to sum up the insulin pen technology invention and improvement which are nowadays the leading mode of an insulin delivery. Even though so many years have passed, insulin is still administered subcutaneously, that is why devices to deliver it are of great importance. Insulin pens have evolved only through the last decades (the reusable, durable pens, and the disposable, prefilled pens) and modern smart insulin pens have been developed in the last few years, and both types of the devices compared to traditional syringes and vials are more convenient, discrete in use, have better dosing accuracy, and improve adherence. In this review, we will focus on the history of insulin pens and their improvement over the previous decades.
format Online
Article
Text
id pubmed-8959107
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89591072022-03-29 The Review of Insulin Pens—Past, Present, and Look to the Future Masierek, Małgorzata Nabrdalik, Katarzyna Janota, Oliwia Kwiendacz, Hanna Macherski, Maksymilian Gumprecht, Janusz Front Endocrinol (Lausanne) Endocrinology Currently, there are about 150–200 million diabetic patients treated with insulin globally. The year 2021 is special because the 100th anniversary of the insulin discovery is being celebrated. It is a good occasion to sum up the insulin pen technology invention and improvement which are nowadays the leading mode of an insulin delivery. Even though so many years have passed, insulin is still administered subcutaneously, that is why devices to deliver it are of great importance. Insulin pens have evolved only through the last decades (the reusable, durable pens, and the disposable, prefilled pens) and modern smart insulin pens have been developed in the last few years, and both types of the devices compared to traditional syringes and vials are more convenient, discrete in use, have better dosing accuracy, and improve adherence. In this review, we will focus on the history of insulin pens and their improvement over the previous decades. Frontiers Media S.A. 2022-03-08 /pmc/articles/PMC8959107/ /pubmed/35355552 http://dx.doi.org/10.3389/fendo.2022.827484 Text en Copyright © 2022 Masierek, Nabrdalik, Janota, Kwiendacz, Macherski and Gumprecht https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Masierek, Małgorzata
Nabrdalik, Katarzyna
Janota, Oliwia
Kwiendacz, Hanna
Macherski, Maksymilian
Gumprecht, Janusz
The Review of Insulin Pens—Past, Present, and Look to the Future
title The Review of Insulin Pens—Past, Present, and Look to the Future
title_full The Review of Insulin Pens—Past, Present, and Look to the Future
title_fullStr The Review of Insulin Pens—Past, Present, and Look to the Future
title_full_unstemmed The Review of Insulin Pens—Past, Present, and Look to the Future
title_short The Review of Insulin Pens—Past, Present, and Look to the Future
title_sort review of insulin pens—past, present, and look to the future
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959107/
https://www.ncbi.nlm.nih.gov/pubmed/35355552
http://dx.doi.org/10.3389/fendo.2022.827484
work_keys_str_mv AT masierekmałgorzata thereviewofinsulinpenspastpresentandlooktothefuture
AT nabrdalikkatarzyna thereviewofinsulinpenspastpresentandlooktothefuture
AT janotaoliwia thereviewofinsulinpenspastpresentandlooktothefuture
AT kwiendaczhanna thereviewofinsulinpenspastpresentandlooktothefuture
AT macherskimaksymilian thereviewofinsulinpenspastpresentandlooktothefuture
AT gumprechtjanusz thereviewofinsulinpenspastpresentandlooktothefuture
AT masierekmałgorzata reviewofinsulinpenspastpresentandlooktothefuture
AT nabrdalikkatarzyna reviewofinsulinpenspastpresentandlooktothefuture
AT janotaoliwia reviewofinsulinpenspastpresentandlooktothefuture
AT kwiendaczhanna reviewofinsulinpenspastpresentandlooktothefuture
AT macherskimaksymilian reviewofinsulinpenspastpresentandlooktothefuture
AT gumprechtjanusz reviewofinsulinpenspastpresentandlooktothefuture